HEC Management GP LLC, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 21,032 shares at $62.56 ($1.3M) on 2019-10-21, disclosed to the SEC on 2019-10-23.
Open-market sale of $1.3M EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.56 | 3,849 | $241K | 18.3% |
| 2 | $62.56 | 3,849 | $241K | 18.3% |
| 3 | $62.68 | 6,567 | $412K | 31.2% |
| 4 | $62.68 | 6,567 | $412K | 31.2% |
| 5 | $62.58 | 200 | $13K | 1.0% |
| Total | $62.64 avg | 21,032 |
| $1.3M |
| 100% |
| Filing → |
| USAT | BUY | 2019-09-23 | $639K | — | Filing → |
| EGRX | SELL | 2019-09-13 | $146K | — | Filing → |
| CATM | BUY | 2018-02-23 | $14.9M | — | Filing → |